The Pfizer vaccine, developed with the German pharmaceutical company BioNTech, requires a storage temperature of about minus 70 degrees Celsius
The national information platform on vaccination against COVID-19 informed on Thursday that the BioNTech-Pfizer vaccine will be used in the European Union only after a careful scientific evaluation attesting that it meets all the conditions provided for in the existing rules.
Greece expects to receive 300,000 Covid-19 vaccine doses in the first tranche, which means that 150,000 people will be vaccinated initially (vaccines will require two doses per patient), government spokesman Stelios Petsas told Parapolitika radio on Wednesday.
Petsas said that the immunization program will be launched in December or January.
European nations vowed on Dec. 16 to get their coronavirus vaccination campaigns rolling before the end of the year while a surge in infections prompted tighter restrictions across several countries.
Germany will begin vaccinations on December 27, its health minister said, detailing a timeline expected to be mirrored across the European Union's 27 member states.